Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003

Clinical trial NCT06714006 · RECRUITING

Trial details

NCT number: NCT06714006
Sponsor: PYC Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Start date: 2025-04-07
Primary completion: 2028-11-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.